会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • DISPLACEABLE LINKER SOLID PHASE CHEMICAL LIGATION
    • 可拆卸连接器固体相化学发光
    • WO2004105685A2
    • 2004-12-09
    • PCT/US2004015435
    • 2004-05-17
    • GRYPHON THERAPEUTICS INCLOW DONALDHU YINGBOTTI PAOLO
    • LOW DONALDHU YINGBOTTI PAOLO
    • A61K20060101C07K1/04C07K1/107C08B37/00C08F2/00A61K
    • C07K1/042C07K1/1072
    • The invention is directed to methods and compositions for aqueous-compatible solid phase chemical ligation. The methods and compositions of the invention involve the chemical ligation of first and second polymers, where the first polymer is attached to a support through a displaceable linker. The displaceable linker can be cleaved or otherwise displaced under aqueous conditions compatible with subsequent removal of the ligation product from the solid support. The methods and compositions of the invention are particularly useful for ligation of peptides and polypeptides on a solid support. The ligation system of the invention is applicable to a wide variety of molecules, and thus can be exploited to generate ligated polymers including peptides, polypeptides and other amino acid containing polymers.
    • 本发明涉及用于水相容性固相化学连接的方法和组合物。 本发明的方法和组合物涉及第一和第二聚合物的化学连接,其中第一聚合物通过位移连接体连接到载体上。 在与固体支持物随后除去连接产物相容的水性条件下,可置换接头可以被切割或以其它方式置换。 本发明的方法和组合物特别可用于在固体支持物上连接肽和多肽。 本发明的连接系统可应用于各种各样的分子,因此可用于产生连接的聚合物,包括肽,多肽和其它含氨基酸的聚合物。
    • 9. 发明申请
    • FORMULATIONS COMPRISING CYCLIC COMPOUNDS
    • 包含环化合物的制剂
    • WO2008037484A3
    • 2008-12-18
    • PCT/EP2007008442
    • 2007-09-27
    • BOTTI PAOLO
    • BOTTI PAOLO
    • A61K47/22A61K31/365A61K47/14C07D323/00
    • C07D323/00A61K47/22A61K47/6949B82Y5/00
    • This invention relates to the use of a cyclic compound of formula (I), wherein A, B independently in each occurrence is alkane-i,j-diyl having k carbon atoms, i and independently j being less than or equal k and k being selected from 1 to 10, wherein said alkane-i,j-diyl (i) may comprise one or more double bonds; (ii) is optionally substituted; and/or (iii) comprises a cycle, wherein the total number of cycles being cyclic sugars in said compound is selected from 0 to 4 and is less than p (n+m); X,Y independently in each occurrence is a biocompatible functional group comprising at least one oxygen atom or two sulphur atoms; n, m independently of each other are selected from 0 to 20; p is selected from 1 to 10; n+m is equal or greater than 1; and p.(n+m) is selected from 3 to 30; wherein said compound is capable of forming a complex with a protonated primary and/or protonated secondary amino group and/or a protonated guanidinium group for the manufacture of a pharmaceutical or diagnostic composition further comprising a pharmaceutically or diagnostically active agent, said active agent comprising one or more protonated primary and/or protonated secondary amino groups and/or a protonated guanidinium groups, wherein (a) transmembrane and/or transmucosal delivery; (b) solubility in non-aqueous solvents; and/or (c) stability of said active agent are improved.
    • 本发明涉及式(I)环状化合物的用途,其中A,B在每种情况下独立地为具有k个碳原子的链烷-ε,j-二基,i和独立地j小于或等于k且k为 选自1至10,其中所述烷烃-i,j-二基(i)可以包含一个或多个双键; (ii)任选被取代; 和/或(iii)包括一个循环,其中所述化合物中循环糖的总循环次数选自0至4且小于p(n + m);和/或(iii)包含循环。 X,Y在每种情况下独立地为包含至少一个氧原子或两个硫原子的生物相容性官能团; n,m彼此独立地选自0至20; p选自1至10; n + m等于或大于1; 并且p(n + m)选自3至30; 其中所述化合物能够与质子化的伯氨基和/或质子化的仲氨基和/或质子化的胍基形成复合物用于制备还包含药学或诊断活性剂的药物或诊断组合物,所述活性剂包含一种 或质子化的主要和/或质子化的仲氨基和/或质子化的胍基,其中(a)跨膜和/或透粘膜递送; (b)在非水溶剂中的溶解度; 和/或(c)所述活性剂的稳定性得到改善。